Indeed, JAK2V617F expression in LNK-deficient murine bone marrow cells rendered the cells significantly more sensitive to transformation by JAK2 oncogene compared to wild-type cells in clonogenic assays and accelerated the onset of JAK2V617F PV in mice [87,88]. Here, JAK2 is linked to acquired polycythemia vera.